Cargando…
Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496013/ https://www.ncbi.nlm.nih.gov/pubmed/37705908 http://dx.doi.org/10.1016/j.ekir.2023.06.008 |
| _version_ | 1785105017667059712 |
|---|---|
| author | Takazono, Takahiro Ngwe Tun, Mya Myat Funakoshi, Satoshi Morimoto, Shimpei Ota, Kenji Torigoe, Kenta Abe, Shinichi Muta, Kumiko Ito, Yuya Ashizawa, Nobuyuki Kitamura, Mineaki Takeda, Kazuaki Iwanaga, Naoki Ide, Shotaro Tashiro, Masato Hosogaya, Naoki Nishino, Tomoya Yanagihara, Katsunori Izumikawa, Koichi Morita, Kouichi Mukae, Hiroshi |
| author_facet | Takazono, Takahiro Ngwe Tun, Mya Myat Funakoshi, Satoshi Morimoto, Shimpei Ota, Kenji Torigoe, Kenta Abe, Shinichi Muta, Kumiko Ito, Yuya Ashizawa, Nobuyuki Kitamura, Mineaki Takeda, Kazuaki Iwanaga, Naoki Ide, Shotaro Tashiro, Masato Hosogaya, Naoki Nishino, Tomoya Yanagihara, Katsunori Izumikawa, Koichi Morita, Kouichi Mukae, Hiroshi |
| author_sort | Takazono, Takahiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10496013 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104960132023-09-13 Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients Takazono, Takahiro Ngwe Tun, Mya Myat Funakoshi, Satoshi Morimoto, Shimpei Ota, Kenji Torigoe, Kenta Abe, Shinichi Muta, Kumiko Ito, Yuya Ashizawa, Nobuyuki Kitamura, Mineaki Takeda, Kazuaki Iwanaga, Naoki Ide, Shotaro Tashiro, Masato Hosogaya, Naoki Nishino, Tomoya Yanagihara, Katsunori Izumikawa, Koichi Morita, Kouichi Mukae, Hiroshi Kidney Int Rep Research Letter Elsevier 2023-06-17 /pmc/articles/PMC10496013/ /pubmed/37705908 http://dx.doi.org/10.1016/j.ekir.2023.06.008 Text en © 2023 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Takazono, Takahiro Ngwe Tun, Mya Myat Funakoshi, Satoshi Morimoto, Shimpei Ota, Kenji Torigoe, Kenta Abe, Shinichi Muta, Kumiko Ito, Yuya Ashizawa, Nobuyuki Kitamura, Mineaki Takeda, Kazuaki Iwanaga, Naoki Ide, Shotaro Tashiro, Masato Hosogaya, Naoki Nishino, Tomoya Yanagihara, Katsunori Izumikawa, Koichi Morita, Kouichi Mukae, Hiroshi Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients |
| title | Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients |
| title_full | Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients |
| title_fullStr | Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients |
| title_full_unstemmed | Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients |
| title_short | Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients |
| title_sort | long-term neutralizing antibody titers after bnt162b2 vaccination in hemodialysis patients |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496013/ https://www.ncbi.nlm.nih.gov/pubmed/37705908 http://dx.doi.org/10.1016/j.ekir.2023.06.008 |
| work_keys_str_mv | AT takazonotakahiro longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT ngwetunmyamyat longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT funakoshisatoshi longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT morimotoshimpei longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT otakenji longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT torigoekenta longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT abeshinichi longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT mutakumiko longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT itoyuya longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT ashizawanobuyuki longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT kitamuramineaki longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT takedakazuaki longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT iwanaganaoki longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT ideshotaro longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT tashiromasato longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT hosogayanaoki longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT nishinotomoya longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT yanagiharakatsunori longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT izumikawakoichi longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT moritakouichi longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients AT mukaehiroshi longtermneutralizingantibodytitersafterbnt162b2vaccinationinhemodialysispatients |